Cargando…
Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis
Objective: Peptidylarginine deiminases (PAD) 2 and 4 are key enzymes in rheumatoid arthritis (RA) pathogenesis due to their ability to generate the protein targets of anti-citrullinated protein antibodies (ACPA). Anti-PAD4 antibodies that cross-react with PAD3 (anti-PAD3/4) have been identified and...
Autores principales: | Darrah, Erika, Giles, Jon T., Davis, Ryan L., Naik, Pooja, Wang, Hong, Konig, Maximilian F., Cappelli, Laura C., Bingham, Clifton O., Danoff, Sonye K., Andrade, Felipe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255931/ https://www.ncbi.nlm.nih.gov/pubmed/30515171 http://dx.doi.org/10.3389/fimmu.2018.02696 |
Ejemplares similares
-
Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis
por: Cappelli, Laura C., et al.
Publicado: (2018) -
Association of Cross-Reactive Antibodies Targeting Peptidyl-Arginine Deiminase 3 and 4 with Rheumatoid Arthritis-Associated Interstitial Lung Disease
por: Giles, Jon T., et al.
Publicado: (2014) -
Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis
por: Demoruelle, M. Kristen, et al.
Publicado: (2021) -
Peptidylarginine Deiminase 2 Autoantibodies Are Linked to Less Severe Disease in Multiple Sclerosis and Post-treatment Lyme Disease
por: Kim, Yaewon, et al.
Publicado: (2022) -
Analysis of the peptidylarginine deiminase V gene in rheumatoid arthritis
por: Caponi, L, et al.
Publicado: (2003)